DC Field | Value | Language |
---|---|---|
dc.contributor.author | Geng, Chen-Lu | ko |
dc.contributor.author | Chen, Jun-Yi | ko |
dc.contributor.author | Song, Tian -Yu | ko |
dc.contributor.author | Jung, Jae Hyung | ko |
dc.contributor.author | Long, Min | ko |
dc.contributor.author | Song, Min -Fang | ko |
dc.contributor.author | Ji, Tong | ko |
dc.contributor.author | Min, Byung Soh | ko |
dc.contributor.author | Lee, Jin Gu | ko |
dc.contributor.author | Peng, Bo | ko |
dc.contributor.author | Pu, Yi-Sheng | ko |
dc.contributor.author | Fan, Hong-Jie | ko |
dc.contributor.author | Hao, Piliang | ko |
dc.contributor.author | Zhou, Qi | ko |
dc.contributor.author | Shin, Eui-Cheol | ko |
dc.contributor.author | Cang, Yong | ko |
dc.date.accessioned | 2022-10-04T08:00:47Z | - |
dc.date.available | 2022-10-04T08:00:47Z | - |
dc.date.created | 2022-10-04 | - |
dc.date.created | 2022-10-04 | - |
dc.date.created | 2022-10-04 | - |
dc.date.issued | 2022-08 | - |
dc.identifier.citation | CELL CHEMICAL BIOLOGY, v.29, no.8, pp.1260 - + | - |
dc.identifier.issn | 2451-9448 | - |
dc.identifier.uri | http://hdl.handle.net/10203/298804 | - |
dc.description.abstract | Programmed cell death protein 1 (PD-1) checkpoint blockade therapy requires the CD28 co-stimulatory re-ceptor for CD8(+) T cell expansion and cytotoxicity. However, CD28 expression is frequently lost in exhausted T cells and during immune senescence, limiting the clinical benefits of PD-1 immunotherapy in individuals with cancer. Here, using a cereblon knockin mouse model that regains in vivo T cell response to lenalidomide, an immunomodulatory imide drug, we show that lenalidomide reinstates the anti-tumor activity of CD28-defi-cient CD8(+) T cells after PD-1 blockade. Lenalidomide redirects the CRL4(Crbn) ubiquitin ligase to degrade Ikzf1 and Ikzf3 in T cells and unleashes paracrine interleukin-2 (IL-2) and intracellular Notch signaling, which collec-tively bypass the CD28 requirement for activation of intratumoral CD8+ T cells and inhibition of tumor growth by PD-1 blockade. Our results suggest that PD-1 immunotherapy can benefit from a lenalidomide combina-tion when treating solid tumors infiltrated with abundant CD28- T cells. | - |
dc.language | English | - |
dc.publisher | CELL PRESS | - |
dc.title | Lenalidomide bypasses CD28 co-stimulation to reinstate PD-1 immunotherapy by activating Notch signaling | - |
dc.type | Article | - |
dc.identifier.wosid | 000860117400003 | - |
dc.identifier.scopusid | 2-s2.0-85135786442 | - |
dc.type.rims | ART | - |
dc.citation.volume | 29 | - |
dc.citation.issue | 8 | - |
dc.citation.beginningpage | 1260 | - |
dc.citation.endingpage | + | - |
dc.citation.publicationname | CELL CHEMICAL BIOLOGY | - |
dc.identifier.doi | 10.1016/j.chembiol.2022.05.012 | - |
dc.contributor.localauthor | Shin, Eui-Cheol | - |
dc.contributor.nonIdAuthor | Geng, Chen-Lu | - |
dc.contributor.nonIdAuthor | Chen, Jun-Yi | - |
dc.contributor.nonIdAuthor | Song, Tian -Yu | - |
dc.contributor.nonIdAuthor | Long, Min | - |
dc.contributor.nonIdAuthor | Song, Min -Fang | - |
dc.contributor.nonIdAuthor | Ji, Tong | - |
dc.contributor.nonIdAuthor | Min, Byung Soh | - |
dc.contributor.nonIdAuthor | Lee, Jin Gu | - |
dc.contributor.nonIdAuthor | Peng, Bo | - |
dc.contributor.nonIdAuthor | Pu, Yi-Sheng | - |
dc.contributor.nonIdAuthor | Fan, Hong-Jie | - |
dc.contributor.nonIdAuthor | Hao, Piliang | - |
dc.contributor.nonIdAuthor | Zhou, Qi | - |
dc.contributor.nonIdAuthor | Cang, Yong | - |
dc.description.isOpenAccess | N | - |
dc.type.journalArticle | Article | - |
dc.subject.keywordAuthor | CD28 | - |
dc.subject.keywordAuthor | CRBN | - |
dc.subject.keywordAuthor | immunotherapy | - |
dc.subject.keywordAuthor | lenalidomide | - |
dc.subject.keywordAuthor | Notch signaling | - |
dc.subject.keywordAuthor | PD-1 | - |
dc.subject.keywordPlus | T-CELLS | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | PHASE-I | - |
dc.subject.keywordPlus | DEGRADATION | - |
dc.subject.keywordPlus | THALIDOMIDE | - |
dc.subject.keywordPlus | THERAPY | - |
dc.subject.keywordPlus | ANTIGEN | - |
dc.subject.keywordPlus | IKAROS | - |
dc.subject.keywordPlus | RESPONSIVENESS | - |
dc.subject.keywordPlus | LYMPHOCYTES | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.